Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 8/20 | 0.47 |
| ▸ | SPHK1 | Q9NYA1 | 5/20 | 0.46 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.43 |
| ▸ | CASP2 | P42575 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | RRM1 | P23921 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1428105 | 1.00 | EPHX1 (0.47) | EPHX1SPHK1SPHK2CASP2MEN1 | |
| SCHEMBL4111428 | 1.00 | EPHX1 (0.47) | EPHX1SPHK1SPHK2CASP2MEN1 | |
| Polihexanide SCHEMBL45011 | 1.00 | EPHX1 (0.47) | EPHX1SPHK1SPHK2CASP2MEN1 | |
| SCHEMBL245909 | 1.00 | EPHX1 (0.47) | EPHX1SPHK1SPHK2CASP2MEN1 | |
| SCHEMBL3921623 | 1.00 | EPHX1 (0.47) | EPHX1SPHK1SPHK2CASP2MEN1 | |
| Hydrochloric Acid SCHEMBL9667167 | 0.98 | SPHK1 (0.49) | EPHX1SPHK1SPHK2CASP2MEN1 | |
| Hydrochloric Acid SCHEMBL8898546 | 0.98 | SPHK1 (0.49) | EPHX1SPHK1SPHK2CASP2MEN1 | |
| Polihexanide SCHEMBL115297 | 0.98 | SPHK1 (0.49) | EPHX1SPHK1SPHK2CASP2MEN1 | |
| Polihexanide SCHEMBL6770315 | 0.98 | EPHX1 (0.45) | EPHX1SPHK1SPHK2CASP2MEN1 | |
| Polihexanide SCHEMBL8515092 | 0.98 | SPHK1 (0.49) | EPHX1SPHK1SPHK2CASP2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3083862-B1 | ANTIMICROBIAL PRESSURE-SENSITIVE ADHESIVE SYSTEM | 3M INNOVATIVE PROPERTIES CO (US) | 2020-08-05 | — | — | EP | claimed |
| US-8563011-B2 | Use of low molecular weight amino alcohols in ophthalmic compositions | ALCON RESEARCH, LTD. (US) | 2013-10-22 | — | — | US | claimed |
| CN-115746855-A | Treatment liquid | 富士胶片株式会社 | 2023-03-07 | — | — | CN | disclosed |
| CN-109844008-B | Rubber composition and crosslinked rubber | 日本瑞翁株式会社 | 2021-08-24 | — | — | CN | disclosed |
| US-10898857-B2 | Membranes with alternative selective layers | Oasys Water LLC (US) | 2021-01-26 | — | — | US | disclosed |
| CN-108485840-B | Cleaning formulation for removing residues on surfaces | 富士胶片电子材料美国有限公司 | 2020-12-29 | — | — | CN | disclosed |
| US-20190217249-A1 | MEMBRANES WITH ALTERNATIVE SELECTIVE LAYERS | CHINA CAMC ENGINEERING HONGKONG CO., LIMITED (HK) | 2019-07-18 | — | — | US | disclosed |
| WO-2018049013-A1 | MEMBRANES WITH ALTERNATIVE SELECTIVE LAYERS | OASYS WATER, INC. (US) | 2018-03-15 | — | — | WO | disclosed |
| EP-3071319-A1 | SYSTEMS AND METHODS FOR REPAIRING MEMBRANES AND IMPROVING PERFORMANCE OF OSMOTICALLY DRIVEN MEMBRANE SYSTEMS | Oasys Water, Inc. (US) | 2016-09-28 | — | — | EP | disclosed |
| US-20150136676-A1 | SYSTEMS AND METHODS FOR REPAIRING MEMBRANES AND IMPROVING PERFORMANCE OF OSMOTICALLY DRIVEN MEMBRANE SYSTEMS | Oasys Water LLC | 2015-05-21 | — | — | US | disclosed |
| US-20140322287-A1 | BIOACTIVE COATINGS | BIOINTERACTIONS LTD. (GB) | 2014-10-30 | — | — | US | disclosed |
| US-7045095-B2 | Efficiency microbiocides, preservatives; mixture containing sodium borarte; antiseptic for contact lenses | ALCON MANUFACTURING, LTD. (US) | 2006-05-16 | — | — | US | disclosed |
| US-20050239900-A1 | Efficiency microbiocides, preservatives; mixture containing sodium borarte; antiseptic for contact lenses | ALCON RESEARCH, LTD. | 2005-10-27 | — | — | US | disclosed |
| US-6949218-B2 | Enhancing the anti-microbial activity of a borate-containing compound which comprises adding to the composition an effective amount of a low molecular weight amino alcohol, wherein the amino alcohol has a molecular weight of 60-200 | ALCON MANUFACTURING, LTD. (US) | 2005-09-27 | — | — | US | disclosed |
| US-20020106304-A1 | Enhancing the anti-microbial activity of a borate-containing compound which comprises adding to the composition an effective amount of a low molecular weight amino alcohol, wherein the amino alcohol has a molecular weight of 60-200 | ALCON RESEARCH, LTD. | 2002-08-08 | — | — | US | disclosed |
| EP-0948357-B1 | USE OF LOW MOLECULAR WEIGHT AMINO ALCOHOLS IN OPHTHALMIC COMPOSITIONS | ALCON LAB INC (US) | 2002-06-12 | — | — | EP | disclosed |
| EP-1190718-A2 | Ophthalmic compositions comprising amino alcohols | ALCON LABORATORIES, INC. (US) | 2002-03-27 | — | — | EP | disclosed |
| US-6319464-B1 | ADDED TO BORATE CONTAINING COMPOUND; ANTIMICROBIAL ACTIVITY ENHANCEMENT | ALCON MANUFACTURING, LTD. | 2001-11-20 | — | — | US | disclosed |
| EP-0948357-A1 | USE OF LOW MOLECULAR WEIGHT AMINO ALCOHOLS IN OPHTHALMIC COMPOSITIONS | ALCON LABORATORIES, INC. (US) | 1999-10-13 | — | — | EP | disclosed |
| WO-1998025649-A1 | USE OF LOW MOLECULAR WEIGHT AMINO ALCOHOLS IN OPHTHALMIC COMPOSITIONS | ALCON LABORATORIES, INC. (US) | 1998-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140322287-A1 | BIOACTIVE COATINGS | SERPINC1, PLAT, FGB | EPHX1 2337/4885SPHK1 3312/4885SPHK2 3827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.